Use of a novel interactive digital therapeutic intervention for the management of delirium in the critical care environment

There is a huge human and financial cost to delirium, which is defined as a fluctuating state of confusion and agitation experienced by up to 80% of critical care patients. Delirium is associated with increased risk of death and worsened outcomes like lasting changes in cognition. Our team has partnered with BC tech company MindfulGarden (MG) Digital Health Inc, to develop a novel digital therapeutic intervention. MG utilizes inbuilt sensors and screen based delivery systems to create a calming experience powered by patient-generated input. MG aims to distract and calm patients with delirium-related agitation. We propose a series of randomized clinical trials with critical care patients suffering from delirium to determine the feasibility and effectiveness of this technology as an adjunct to standard care. We hypothesize this will result in reductions in agitation behaviors, reliance on toxic medications and use of restraints in delirious patients in critical care environments.

Faculty Supervisor:

Steven Reynolds

Student:

Partner:

Mindful Garden

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services

University:

Simon Fraser University

Program: